Nations Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
LMFP
PR
AAS
WAM
RFM
NHFG
MFS
LRPA
SGH
EWM
Nations Financial Group's XBI Position: Q2 2026 in Review
Nations Financial Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 9.3% in Q2 2026, selling an estimated $94.6K and leaving 6,835 shares worth $1.08M. The position accounts for 0.05% of the portfolio, ranked #359.
Nations Financial Group first reported a position in XBI in Q2 2020 and has held it in 20 quarters since. The position peaked at $3M in Q3 2024. 254 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Nations Financial Group held 6,835 shares of State Street SPDR S&P Biotech ETF worth $1.08M as of Q2 2026.
- Nations Financial Group sold 700 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $94.6K.
- State Street SPDR S&P Biotech ETF made up 0.05% of Nations Financial Group's portfolio in Q2 2026, its #359 holding.
- Nations Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 20 quarters since.
- Nations Financial Group's State Street SPDR S&P Biotech ETF position peaked at $3M in Q3 2024.
- 254 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.